Haidich A-B

Konstas A G P, Quaranta L, Yan D B, Mikropoulos D G, Riva I, Gill N K et al.

This study compared two glaucoma fixed combinations, finding dorzolamide/timolol provided superior 24-hour IOP reduction compared to brimonidine/timolol in primary open-angle glaucoma, offering better pressure control.

Konstas A G P, Mikropoulos D G, Embeslidis T A, Dimopoulos A T, Papanastasiou A, Haidich A-B et al.

This study found travoprost/timolol fixed combination provided superior 24-hour IOP control, including lower mean and peak pressures, compared to latanoprost/timolol in exfoliative glaucoma, offering a potentially more effective treatment option.

Konstas A G P, Mikropoulos D, Haidich A-B, Ntampos K S, Stewart W C

This study found travoprost/timolol fixed combination significantly lowered 24-hour intraocular pressure and fluctuation more than travoprost alone in glaucoma patients, offering superior IOP control.

Quaranta L, Pizzolante T, Riva I, Haidich A-B, Konstas A G P, Stewart W C

In normal-tension glaucoma, bimatoprost and latanoprost similarly lower 24-hour IOP. Latanoprost slightly improved ocular perfusion pressure, but both drugs yielded comparable overall perfusion and IOP reduction, offering similar clinical efficacy.